
Direct-To-Consumer Laboratory Testing Market Size and Share - Outlook Report, Forecast Trends and Growth Analysis (2025-2034)
Description
The global direct-to-consumer laboratory testing market size was valued at USD 12.40 Billion in 2024, driven by the rising prevalence of telemedicine and EHR services across the globe. The market is expected to grow at a CAGR of 26.80% during the forecast period of 2025-2034, with the values likely to rise from USD 15.70 Billion in 2025 to USD 133.23 Billion by 2034.
Direct-To-Consumer Laboratory Testing: Introduction
Direct to consumer laboratory testing involves providing the customer with a generated lab test, where they get direct results from the test without engaging with a physician. It has gained high popularity owing to their rapid, accurate and convenient results. DTC testing may not be available for all diseases but they can help in monitoring a prevailing health condition or identify an infectious disease like COVID-19.
Global Direct-To-Consumer Laboratory Testing Market Analysis
Direct to customer lab tests have become highly common after the sudden outbreak of COVID-19. People have become more familiar and comfortable to at home lab tests. Apart from COVID-19, pregnancy test kits also hold a significant share of the market.
The direct-to-consumer laboratory testing market value is driven by the rising digital and artificial intelligence integration and EHR (electronic health record) prevalence. Local testing labs like LigoLab has launched their own consumer portal to facilitate prompt and convenient delivery of results. These platforms are HIPAA compliant and integrate other medical system software as well. With a vision to go beyond at-home testing, companies like Everly Health have been developing virtual care services for effective diagnostic testing, treatment, and ongoing condition management.
In July 2023, Quest Diagnostics launched the first direct to consumer blood test that works by detecting abnormal levels of beta amyloid. The test is aimed at adults aged 18 years or older with Alzheimer running in the family history or with mild dementia. If the results turn out to be positive, then the patient is directly contacted by a doctor. Such services are projected to fuel the direct to customer laboratory testing market growth in the upcoming years.
Global Direct-To-Consumer Laboratory Testing Market Segmentation
Direct-To-Consumer Laboratory Testing Market Report and Forecast 2025-2034 offers a detailed analysis of the market based on the following segments:
Market Breakup by Sample Type
North America has held a major portion of the direct-to-consumer laboratory testing market share owing to a well organised medical infrastructure. Healthcare professionals have also worked on educating common people with appropriate utilisation of latest technologies. In addition, the increasing innovation due to presence of impactful healthcare companies is a major factor for driving growth. Europe is a key player holding significant part of the market size.
To meet the rising direct-to-consumer laboratory testing market demand, Asia Pacific region has been observing an increase in the at home test kits manufacturing. Being home to a massive percentage of geriatric population, direct-to-consumer laboratory tests come in handy as the older generation cannot physically move all the time. To ensure easy access to test results, the companies have started providing both soft and hard copy of the test results.
Global Direct-To-Consumer Laboratory Testing Market: Competitor Landscape
The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
*Please Note:* The report will take 5 business days to complete, after order confirmation.
Direct-To-Consumer Laboratory Testing: Introduction
Direct to consumer laboratory testing involves providing the customer with a generated lab test, where they get direct results from the test without engaging with a physician. It has gained high popularity owing to their rapid, accurate and convenient results. DTC testing may not be available for all diseases but they can help in monitoring a prevailing health condition or identify an infectious disease like COVID-19.
Global Direct-To-Consumer Laboratory Testing Market Analysis
Direct to customer lab tests have become highly common after the sudden outbreak of COVID-19. People have become more familiar and comfortable to at home lab tests. Apart from COVID-19, pregnancy test kits also hold a significant share of the market.
The direct-to-consumer laboratory testing market value is driven by the rising digital and artificial intelligence integration and EHR (electronic health record) prevalence. Local testing labs like LigoLab has launched their own consumer portal to facilitate prompt and convenient delivery of results. These platforms are HIPAA compliant and integrate other medical system software as well. With a vision to go beyond at-home testing, companies like Everly Health have been developing virtual care services for effective diagnostic testing, treatment, and ongoing condition management.
In July 2023, Quest Diagnostics launched the first direct to consumer blood test that works by detecting abnormal levels of beta amyloid. The test is aimed at adults aged 18 years or older with Alzheimer running in the family history or with mild dementia. If the results turn out to be positive, then the patient is directly contacted by a doctor. Such services are projected to fuel the direct to customer laboratory testing market growth in the upcoming years.
Global Direct-To-Consumer Laboratory Testing Market Segmentation
Direct-To-Consumer Laboratory Testing Market Report and Forecast 2025-2034 offers a detailed analysis of the market based on the following segments:
Market Breakup by Sample Type
- Blood
- Urine
- Saliva
- Others
- Genetic Testing
- Disease Risk Assessment Testing
- CBC
- Diabetes Testing
- TSH Testing
- Others
- Online Platforms/Websites
- Mobile Applications
- Physical Retail Locations
- Telemedicine Services
- Others
- Hospitals
- Clinics
- Specialty Labs
- Diagnostic Centres
- Others
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
North America has held a major portion of the direct-to-consumer laboratory testing market share owing to a well organised medical infrastructure. Healthcare professionals have also worked on educating common people with appropriate utilisation of latest technologies. In addition, the increasing innovation due to presence of impactful healthcare companies is a major factor for driving growth. Europe is a key player holding significant part of the market size.
To meet the rising direct-to-consumer laboratory testing market demand, Asia Pacific region has been observing an increase in the at home test kits manufacturing. Being home to a massive percentage of geriatric population, direct-to-consumer laboratory tests come in handy as the older generation cannot physically move all the time. To ensure easy access to test results, the companies have started providing both soft and hard copy of the test results.
Global Direct-To-Consumer Laboratory Testing Market: Competitor Landscape
The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
- LabCorp
- Quest Diagnostics
- Everlywell
- LetsGetChecked
- HealthTap
- AncestryDNA
- Veritas Genetics
- MyHeritage
- Color Genomics
- Helix
- Orig3n
- Pathway Genomics
- Thermo Fisher Scientific
- Genome Medical
- HealthCheck
*Please Note:* The report will take 5 business days to complete, after order confirmation.
Table of Contents
350 Pages
- 1 Preface
- 1.1 Objectives of the Study
- 1.2 Key Assumptions
- 1.3 Report Coverage – Key Segmentation and Scope
- 1.4 Research Methodology
- 2 Executive Summary
- 3 Global Direct-to-Consumer Laboratory Testing Market Overview
- 3.1 Global Direct-to-Consumer Laboratory Testing Market Historical Value (2018-2024)
- 3.2 Global Direct-to-Consumer Laboratory Testing Market Forecast Value (2025-2034)
- 4 Global Direct-to-Consumer Laboratory Testing Market Landscape
- 4.1 Global Direct-to-Consumer Laboratory Testing Developers Landscape
- 4.1.1 Analysis by Year of Establishment
- 4.1.2 Analysis by Company Size
- 4.1.3 Analysis by Region
- 4.2 Global Direct-to-Consumer Laboratory Testing Product Landscape
- 4.2.1 Analysis by Type
- 4.2.2 Analysis by Technology
- 5 Global Direct-to-Consumer Laboratory Testing Market Dynamics
- 5.1 Market Drivers and Constraints
- 5.2 SWOT Analysis
- 5.3 Porter’s Five Forces Model
- 5.4 Key Demand Indicators
- 5.5 Key Price Indicators
- 5.6 Industry Events, Initiatives, and Trends
- 5.7 Value Chain Analysis
- 6 Global Direct-to-Consumer Laboratory Testing Market Segmentation
- 6.1 Global Direct-to-Consumer Laboratory Testing Market by Sample Type
- 6.1.1 Market Overview
- 6.1.2 Blood
- 6.1.3 Urine
- 6.1.4 Saliva
- 6.1.5 Others
- 6.2 Global Direct-to-Consumer Laboratory Testing Market by Test Type
- 6.2.1 Market Overview
- 6.2.2 Genetic Testing
- 6.2.3 Disease Risk Assessment Testing
- 6.2.4 CBC
- 6.2.5 Diabetes Testing
- 6.2.6 TSH Testing
- 6.2.7 Others
- 6.3 Global Direct-to-Consumer Laboratory Testing Market by Distribution Channel
- 6.3.1 Market Overview
- 6.3.2 Online Platforms/Websites
- 6.3.3 Mobile Applications
- 6.3.4 Physical Retail Locations
- 6.3.5 Telemedicine Services
- 6.3.6 Others
- 6.4 Global Direct-to-Consumer Laboratory Testing Market by End User
- 6.4.1 Market Overview
- 6.4.2 Hospitals
- 6.4.3 Clinics
- 6.4.4 Speciality Labs
- 6.4.5 Diagnostic Centres
- 6.4.6 Others
- 6.5 Global Direct-to-Consumer Laboratory Testing Market by Region
- 6.5.1 Market Overview
- 6.5.2 North America
- 6.5.3 Europe
- 6.5.4 Asia Pacific
- 6.5.5 Latin America
- 6.5.6 Middle East and Africa
- 7 North America Direct-to-Consumer Laboratory Testing Market
- 7.1 Market Share by Country
- 7.2 United States of America
- 7.3 Canada
- 8 Europe Direct-to-Consumer Laboratory Testing Market
- 8.1 Market Share by Country
- 8.2 United Kingdom
- 8.3 Germany
- 8.4 France
- 8.5 Italy
- 8.6 Others
- 9 Asia Pacific Direct-to-Consumer Laboratory Testing Market
- 9.1 Market Share by Country
- 9.2 China
- 9.3 Japan
- 9.4 India
- 9.5 ASEAN
- 9.6 Australia
- 9.7 Others
- 10 Latin America Direct-to-Consumer Laboratory Testing Market
- 10.1 Market Share by Country
- 10.2 Brazil
- 10.3 Argentina
- 10.4 Mexico
- 10.5 Others
- 11 Middle East and Africa Direct-to-Consumer Laboratory Testing Market
- 11.1 Market Share by Country
- 11.2 Saudi Arabia
- 11.3 United Arab Emirates
- 11.4 Nigeria
- 11.5 South Africa
- 11.6 Others
- 12 Patent Analysis
- 12.1 Analysis by Type of Patent
- 12.2 Analysis by Publication year
- 12.3 Analysis by Issuing Authority
- 12.4 Analysis by Patent Age
- 12.5 Analysis by CPC Analysis
- 12.6 Analysis by Patent Valuation
- 12.7 Analysis by Key Players
- 13 Grants Analysis
- 13.1 Analysis by year
- 13.2 Analysis by Amount Awarded
- 13.3 Analysis by Issuing Authority
- 13.4 Analysis by Grant Application
- 13.5 Analysis by Funding Institute
- 13.6 Analysis by NIH Departments
- 13.7 Analysis by Recipient Organization
- 14 Funding Analysis
- 14.1 Analysis by Funding Instances
- 14.2 Analysis by Type of Funding
- 14.3 Analysis by Funding Amount
- 14.4 Analysis by Leading Players
- 14.5 Analysis by Leading Investors
- 14.6 Analysis by Geography
- 15 Partnership and Collaborations Analysis
- 15.1 Analysis by Partnership Instances
- 15.2 Analysis by Type of Partnership
- 15.3 Analysis by Leading Players
- 15.4 Analysis by Geography
- 16 Regulatory Framework
- 16.1 Regulatory Overview
- 16.1.1 US FDA
- 16.1.2 EU EMA
- 16.1.3 INDIA CDSCO
- 16.1.4 JAPAN PMDA
- 16.1.5 Others
- 17 Supplier Landscape
- 17.1 LabCorp
- 17.1.1 Financial Analysis
- 17.1.2 Product Portfolio
- 17.1.3 Demographic Reach and Achievements
- 17.1.4 Mergers and Acquisition
- 17.1.5 Certifications
- 17.2 Quest Diagnostics
- 17.2.1 Financial Analysis
- 17.2.2 Product Portfolio
- 17.2.3 Demographic Reach and Achievements
- 17.2.4 Mergers and Acquisition
- 17.2.5 Certifications
- 17.3 Everlywell
- 17.3.1 Financial Analysis
- 17.3.2 Product Portfolio
- 17.3.3 Demographic Reach and Achievements
- 17.3.4 Mergers and Acquisition
- 17.3.5 Certifications
- 17.4 LetsGetChecked
- 17.4.1 Financial Analysis
- 17.4.2 Product Portfolio
- 17.4.3 Demographic Reach and Achievements
- 17.4.4 Mergers and Acquisition
- 17.4.5 Certifications
- 17.5 HealthTap
- 17.5.1 Financial Analysis
- 17.5.2 Product Portfolio
- 17.5.3 Demographic Reach and Achievements
- 17.5.4 Mergers and Acquisition
- 17.5.5 Certifications
- 17.6 AncestryDNA
- 17.6.1 Financial Analysis
- 17.6.2 Product Portfolio
- 17.6.3 Demographic Reach and Achievements
- 17.6.4 Mergers and Acquisition
- 17.6.5 Certifications
- 17.7 Veritas Genetics
- 17.7.1 Financial Analysis
- 17.7.2 Product Portfolio
- 17.7.3 Demographic Reach and Achievements
- 17.7.4 Mergers and Acquisition
- 17.7.5 Certifications
- 17.8 MyHeritage
- 17.8.1 Financial Analysis
- 17.8.2 Product Portfolio
- 17.8.3 Demographic Reach and Achievements
- 17.8.4 Mergers and Acquisition
- 17.8.5 Certifications
- 17.9 Color Genomics
- 17.9.1 Financial Analysis
- 17.9.2 Product Portfolio
- 17.9.3 Demographic Reach and Achievements
- 17.9.4 Mergers and Acquisition
- 17.9.5 Certifications
- 17.10 Helix
- 17.10.1 Financial Analysis
- 17.10.2 Product Portfolio
- 17.10.3 Demographic Reach and Achievements
- 17.10.4 Mergers and Acquisition
- 17.10.5 Certifications
- 17.11 Orig3n
- 17.11.1 Financial Analysis
- 17.11.2 Product Portfolio
- 17.11.3 Demographic Reach and Achievements
- 17.11.4 Mergers and Acquisition
- 17.11.5 Certifications
- 17.12 Pathway Genomics
- 17.12.1 Financial Analysis
- 17.12.2 Product Portfolio
- 17.12.3 Demographic Reach and Achievements
- 17.12.4 Mergers and Acquisition
- 17.12.5 Certifications
- 17.13 Thermo Fisher Scientific
- 17.13.1 Financial Analysis
- 17.13.2 Product Portfolio
- 17.13.3 Demographic Reach and Achievements
- 17.13.4 Mergers and Acquisition
- 17.13.5 Certifications
- 17.14 Genome Medical
- 17.14.1 Financial Analysis
- 17.14.2 Product Portfolio
- 17.14.3 Demographic Reach and Achievements
- 17.14.4 Mergers and Acquisition
- 17.14.5 Certifications
- 17.15 HealthCheck
- 17.15.1 Financial Analysis
- 17.15.2 Product Portfolio
- 17.15.3 Demographic Reach and Achievements
- 17.15.4 Mergers and Acquisition
- 17.15.5 Certifications
- 18 Global Direct-to-Consumer Laboratory Testing Market - Distribution Model (Additional Insight)
- 18.1 Overview
- 18.2 Potential Distributors
- 18.3 Key Parameters for Distribution Partner Assessment
- 19 Key Opinion Leaders (KOL) Insights (Additional Insight)
- 20 Company Competitiveness Analysis (Additional Insight)
- 20.1 Very Small Companies
- 20.2 Small Companies
- 20.3 Mid-Sized Companies
- 20.4 Large Companies
- 20.5 Very Large Companies
- 21 Payment Methods (Additional Insight)
- 21.1 Government Funded
- 21.2 Private Insurance
- 21.3 Out-of-Pocket
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.